Published online Nov 6, 2020. doi: 10.12998/wjcc.v8.i21.5341
Peer-review started: May 12, 2020
First decision: September 14, 2020
Revised: September 27, 2020
Accepted: October 12, 2020
Article in press: October 12, 2020
Published online: November 6, 2020
Processing time: 178 Days and 5.1 Hours
Donepezil is an acetylcholinesterase inhibitor used to improve cognition and delay disease progression in dementia patients by increasing acetylcholine levels. This drug may potentially interact with neuromuscular blocking agents (NMBAs) that act on muscular acetylcholine receptors during general anesthesia. Herein, we present a case of inadequate neuromuscular blockade with rocuronium, a nondepolarizing NMBA, in a dementia patient who had taken donepezil.
A 71-year-old man was scheduled for laparoscopic gastrectomy. He had been taking donepezil 5 mg for dementia. General anesthesia was induced with propofol and remifentanil. The depth of neuromuscular blockade was monitored by train-of-four (TOF) stimulation. After the administration of rocuronium, the TOF ratio decreased at an unusually slow rate, and a TOF count of 0 was detected 7 min later. After intubation, a TOF count of 1 was detected within 1 min, and a TOF ratio of 12% was detected within 2 min. The TOF count remained at 4 even with an additional bolus and continuous infusion of rocuronium, suggesting resistance to this NMBA. Instead of propofol, an inhalation anesthetic was administered alongside another NMBA (cisatracurium). Then, the quality of neuromuscular blockade improved, and the TOF count remained at 0-1 for the next 70 min. No further problems were encountered with respect to surgery or anesthesia.
Donepezil may be responsible for inadequate neuromuscular blockade during anesthesia, especially when total intravenous anesthesia is used.
Core Tip: In the present case of a 71-year-old patient taking donepezil for dementia, we collected peripheral nerve stimulation data that showed objective evidence of inadequate neuromuscular blockade during total intravenous anesthesia. The goal of this case report is to draw attention to the need to carefully review potential drug interactions between donepezil and neuromuscular blocking agents during general anesthesia. As the number of elderly patients with dementia is increasing and total intravenous anesthesia has become more popular, there is a possibility that this drug interaction may be observed more frequently in the future.